A complete application in a minute
Tailored resume and cover letter, ready to send.
MeiraGTx is seeking a senior QA leader to maintain and improve GxP Quality Systems, ensuring ongoing inspection readiness across the organization. You will train functions in QA practices and supervise a QA System and Compliance team to ensure regulatory compliance.
Key duties include updating procedures to align with current regulations, reviewing regulatory updates, and preparing for audits with both regulators and partners. A science-based background and 10+ years in QA are preferred.
Location: London
Employment type: Full-time, Permanent employee
Your mission
Responsible for the maintenance and continuous improvement of the GxP Quality Systems at MeiraGTx to ensure they remain complaint and inspection ready at all times. Providing ongoing support and training to the functions across MeiraGTx with regard to Quality Assurance. Ensure MeiraGTx remains inspection ready at all times.
MeiraGTx is a clinical-stage gene therapy company focused on developing potentially curative treatments for patients living with serious diseases. We currently have six programs in clinical development including three ocular indications, a salivary gland condition, and a Parkinson's disease program.
Our team was built with deep expertise in gene therapy development, allowing us to efficiently advance our programs from preclinical to clinical development. Our core capabilities in viral vector design and optimization and gene therapy manufacturing give us a differentiated approach to developing gene therapies. Additionally, we are developing proprietary technology to potentially enable innovative gene therapy treatments whose expression can be turned on and off with an easily administered small molecule. We believe temporal control of gene therapy products has the potential to transform the gene therapy landscape.
Our state-of-the-art manufacturing facility, completed in early 2018, was designed to meet global regulatory requirements, including the current good manufacturing practices (cGMP) required by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK and the U.S. Food and Drug Administration (FDA). The 29,000-square foot facility has the flexibility and capacity to produce sufficient product for all our clinical trials and will scale to commercial capacity.